Peters A M, Saverymuttu S H, Keshavarzian A, Bell R N, Lavender J P
Clin Sci (Lond). 1985 Mar;68(3):283-9. doi: 10.1042/cs0680283.
The intrasplenic kinetics of granulocytes, isolated in plasma and labelled in plasma with 111In-tropolonate, have been studied in normal subjects, patients with negative studies for inflammatory disease and patients with positive studies, with the aim of identifying the nature of splenic activity seen after 111In-labelled granulocyte administration. Up to 40 min after injection, 111In activity was visible only in major blood vessels, liver and spleen, with slight, abnormal activity visible in most of those with positive scans. The time courses of uptake of hepatic and splenic activity were different, with liver activity rapidly reaching a plateau and splenic activity increasing mono-exponentially to a plateau achieved between 20 and 40 min. The clear difference between the shapes of the hepatic and splenic uptake curves and the magnitude of the splenic uptake rate constant indicated that splenic activity represented reversible uptake. The application of deconvolution analysis to the blood and splenic time-activity curves generated a splenic retention (or washout) curve consistent with dynamic exchange of granulocytes between blood and spleen. The slope of this curve indicated an intrasplenic granulocyte transit time of 9.3 (+/- SE 0.6) min. Taking splenic activity to be reversible, comparison of the 111In signal from the spleen 40 min after injection of 111In-labelled granulocytes with that given from the spleen after the injection of 111In-labelled erythrocytes (relative to their respective blood levels) indicated that intrasplenic granulocyte transit time was 14.4 (+/- SE 1.1) times that of erythrocytes. Based on actual erythrocyte time, this corresponds to a granulocyte transit time of 8.6-11.5 min, in close agreement with the estimate based on deconvolution analysis.(ABSTRACT TRUNCATED AT 250 WORDS)
在正常受试者、炎症疾病检查结果为阴性的患者以及检查结果为阳性的患者中,研究了分离于血浆并用111铟-托酚酮在血浆中标记的粒细胞在脾内的动力学,目的是确定注射111铟标记的粒细胞后所见脾活性的性质。注射后40分钟内,111铟活性仅在主要血管、肝脏和脾脏中可见,大多数扫描结果为阳性的患者有轻微异常活性。肝脏和脾脏活性的摄取时间进程不同,肝脏活性迅速达到平台期,脾脏活性呈单指数增加,在20至40分钟之间达到平台期。肝脏和脾脏摄取曲线形状的明显差异以及脾脏摄取速率常数的大小表明,脾脏活性代表可逆摄取。对血液和脾脏时间-活性曲线进行去卷积分析,生成了一条与粒细胞在血液和脾脏之间动态交换一致的脾脏滞留(或洗脱)曲线。该曲线的斜率表明脾内粒细胞转运时间为9.3(±标准误0.6)分钟。假设脾脏活性是可逆的,将注射111铟标记的粒细胞后40分钟脾脏的111铟信号与注射111铟标记的红细胞后脾脏的信号(相对于各自的血液水平)进行比较,表明脾内粒细胞转运时间是红细胞的14.4(±标准误1.1)倍。根据实际红细胞时间,这相当于粒细胞转运时间为8.6 - 11.5分钟,与基于去卷积分析的估计值非常一致。(摘要截断于250字)